Studies have shown that patients with peripheral blood eosinophilia (≥150/μL) benefit more from anti-IL-5 therapy, and it is therefore recommended for severe asthma with marked eosinophilia, regardless of whether it is allergic or not. Here, IL5 is linked to Increased total eosinophil count.